Sign Up | Log In | What is SocialPicks?

APP Pharmaceuticals (APPX) Trade Now » Rate APPX - Discuss APPX - Add to Watch List

Sector: Healthcare > Industry: Biotechnology & Drugs

This is a micro-cap stock and may be a target of manipulation. Always do your research!

SocialPicks Sentiment:

N/A

** not enough data to be rated

This Quarter's Sentiment:

All:

100.0%

Top:

100.0%

Rate APPX:

Home

Analysis & Videos

Quotes

Bull or Bear

Discuss

APPX Analysis & Videos »

... View All >

APPX: Bull or Bear?

APP Pharmaceuticals APPX

62%

APP Pharmaceuticals, Inc. (Nasdaq:APPX), a leading provider of hospital-based injectable pharmaceutical products, and Fresenius SE (XETRA:FRE), a global health care group with approximately $18B of sales in products and services for hospital, dialysis and in home medical care, today announced that they have entered into a definitive merger agreement pursuant to which Fresenius will acquire APP.

<> Under the terms of the agreement, Fresenius will acquire the outstanding common stock of APP for $23.00 in cash per share (the "Cash Purchase Price") plus a contingent value right ("CVR") that ...

Continue reading »

By Marian Filo (-24.55% risk: aggressive) 07/08/08

Comment

... View All >

People Bullish on APPX

medo

Analyst

N/A

11 mos ago

Marian Filo

Principal

62%

12 mos ago

tony ng

Analyst

N/A

12 mos ago

People Bearish on APPX

... View All >

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+43.39%	272
2	Gerald Greene	18.14	+59.31%	139
3	stockmarketfunding.com	17.66	+22.00%	34
4	akiralegrand	13.47	+15.91%	48
5	anup2104	12.13	+37.83%	12

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
PG	The Procter & Gamble Company
IBM	International Business Machines Corp
WMT	WalMart Stores Inc
DELL	Dell Inc
GM	General Motors Corp
MSFT	Microsoft Corp

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

PLX		BioMedReports: FDA Calendar Updates by Mike Havrilla
HX		Halifax Confident About Pushing Towards Profitibility by The GeoTeam
APPY		Extreme FDA Medical Device Trades: 7 Stocks Under $5 by Mike Havrilla
ARYX		Extreme FDA Calendar Trades: 18 Stocks Under $5 by Mike Havrilla
DGX		Quest Diagnostics Inc. by Marian Filo

... more »

StreetInsider.com on APPX

Form 4 DePina Stuart For: Sep 10

Form 4 Pizza Joseph M For: Sep 10

Form 4 APP Pharmaceuticals, For: Sep 10 Filed by: California Capital Limited Partnership

Form 4 APP Pharmaceuticals, For: Sep 10 Filed by: Themba 2005 Trust II

Form 4 SOON SHIONG PATRICK For: Sep 10

Discussion Wall

+ Add

Be the first to start a discussion and earn 2 points.

... more »

More Resources

About APP Pharmaceuticals - Answers.com

Historical Prices - Yahoo

Message Boards - BoardCentral.com

More Info: Yahoo | Google | Reuters

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.